title: New drugs 04, part 1.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D000068879:Adalimumab; D000077944:Alefacept; D000840:Anisoles / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D017277:Drug Approval; D004358:Drug Therapy / Q000451:nursing / Q000592:standards / Q000639:trends*; D000795:Fabry Disease / Q000188:drug therapy; D000077156:Gefitinib; D006801:Humans; D007068:Iduronidase / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D007527:Isoenzymes / Q000627:therapeutic use; D007911:Lentigo / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D008059:Mucopolysaccharidosis I / Q000188:drug therapy; D009574:Nitro Compounds; D010353:Patient Education as Topic; D011437:Propylamines / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D011759:Pyrrolidines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D014363:Tryptamines; D000519:alpha-Galactosidase / Q000627:therapeutic use
chemical_list: D000840:Anisoles; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000975:Antioxidants; D000981:Antiprotozoal Agents; D018501:Antirheumatic Agents; D007211:Indoles; D007527:Isoenzymes; D009574:Nitro Compounds; D011437:Propylamines; D011759:Pyrrolidines; D011799:Quinazolines; D011993:Recombinant Fusion Proteins; D017366:Serotonin Receptor Agonists; D013844:Thiazoles; D014363:Tryptamines; C115647:eletriptan; D000069445:Atomoxetine Hydrochloride; C009760:mequinol; D000519:alpha-Galactosidase; D007068:Iduronidase; D000077944:Alefacept; D000068879:Adalimumab; C459420:agalsidase beta; D000077156:Gefitinib; C041747:nitazoxanide